TAYLORE CHESLA: Open Payments
NPI 1013430594 · SAYRE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$367 in 21 payments from 7 companies in 2025. Trend: 2023 $584 · 2024 $811 · 2025 $367
Food & beverage: $367
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $111 |
| Novo Nordisk Inc | 4 | $69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| BridgeBio Pharma, Inc. | 3 | $57 |
| PFIZER INC. | 3 | $43 |
| Amgen Inc. | 1 | $14 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: LEQVIO, JARDIANCE, Attruby, Wegovy, ELIQUIS, Rybelsus, REPATHA, VYNDAQEL.
Industry payments across PA — which companies pay providers there.
